Farms.com Home   News

RDAR Invests in Alberta Regional Silage Trial Program

RDAR is investing $150,000 for 2-year funding for a project to operate regional silage trial program in Alberta. 

The goal of the project is to conduct Regional Silage Trials in a very targeted and controlled method focusing on delivering high quality data that is relevant to the Alberta livestock and crop sectors. 

Efficiency and results are primary drivers of the new project. Hence a very compact program will be operated for the next 2 years focusing on delivering data in areas with high silage acreage. In building the proposal, other prairie provinces as well as cattle feeders, beef and dairy sectors in Alberta have been consulted. The rising cost of operating the project has also been taken into consideration, with coordination of sites to be within proximity of other regional variety trial sites to ensure efficiency for both trial coordinators and site cooperators. Rigor of the project will be ensured by adopting the bylaws, policies, procedures, and protocols of ARVAC*, and amending to fit silage trials where appropriate. 

This program will constantly be evaluated for efficiency and relevancy, which is intended to operate a project that delivers value to the agriculture sector in Alberta. 

Click here to see more...

Trending Video

The Future of Swine Health: Advanced Diagnostics and Customized Vaccines

Video: The Future of Swine Health: Advanced Diagnostics and Customized Vaccines


In this interview, Jay Halliday of Vaxxinova US discusses how advanced diagnostic technologies are helping pork producers better identify, monitor, and respond to disease challenges within their herds.
Unlike traditional diagnostic methods, WGS enables the identification of multiple pathogens within a sample, supports surveillance of emerging variants, helps evaluate feedback programs, and improves isolate selection for autogenous vaccine development.
The conversation also explores the importance of customized vaccine solutions and the role of adjuvants such as Amplivac™ and Trigen™ in enhancing immune responses against key swine pathogens.